On Monday, Shares of NetScout Systems, Inc. (NASDAQ:NTCT), lost -0.76% to $36.58.
NetScout Systems, Inc. (NTCT), a market leader in service assurance and cyber security solutions, declared recently that the Company plans to take part in the investor conference on Wednesday, September 16, 2015, at New York City.
NetScout Systems, Inc., together with its auxiliaries, designs, develops, manufactures, markets, licenses, sells, and supports network, application, and service assurance solutions in the United States, Europe, Asia, and internationally.
Shares of T. Rowe Price Group Inc (NASDAQ:TROW), declined -0.59% to $70.58, during its last trading session.
- Rowe Price Group, declared that its board of directors has elected H. Lawrence “Larry” Culp, Jr. and Alan D. Wilson to be independent directors of the company.
Mr. Culp was chief executive officer and president of Danaher Corporation from 2001 to 2014 and is now a senior advisor to the company. He serves as chair of the Board of Visitors and Governors for Washington College and as a member of the Board of Trustees of Wake Forest University. Mr. Culp recently joined the faculty of the Harvard Business School as a senior lecturer and in 2014 he ranked 38th on Harvard Business Review’s list of the 100 best-performing CEOs in the world.
Mr. Culp holds a Bachelor of Arts degree from Washington College and an M.B.A from Harvard Business School.
- Rowe Price Group, Inc. is a publicly owned asset administration holding company. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions.
At the end of Monday’s trade, Shares of Genesee & Wyoming Inc (NYSE:GWR), lost -2.16% to $61.24.
Genesee & Wyoming, Chief Financial Officer T.J. Gallagher will present at the Citi Industrials Conference in Boston on Wednesday, Sept. 16, 2015, at 11 a.m. EDT.
Genesee & Wyoming Inc. owns and operates short line and regional freight railroads, and provides railcar switching and other rail-related services. It operates in two segments, North American & European Operations and Australian Operations.
Finally, Myriad Genetics, Inc. (NASDAQ:MYGN), ended its last trade with 2.11% gain, and closed at $39.27.
Myriad Genetics, declared that Mark C. Capone, president and CEO, Myriad Genetics, is planned to present at the Morgan Stanley Healthcare Conference at 9:20 a.m. EDT on September 18, 2015, at the Grand Hyatt in New York City, New York.
Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. It discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, diagnose disease, assess the risk of disease progression, and guide treatment decisions across six medical specialties where molecular diagnostics can enhance patient care and lower healthcare costs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
